Effectiveness of sharp recanalization of superior vena cava-right atrium junction occlusion

por Wu, Xiao-Wen, Zhao, Xu-Ya, Li, Xing, Li, Jun-Xiang, Liu, Zong-Yang, Huang, Zhi, Zhang, Ling, Sima, Chong-Yang, Huang, Yu, Chen, Lei, Zhou, Shi
Publicado 2021

CircC16orf62 promotes hepatocellular carcinoma progression through the miR-138-5p/PTK2/AKT axis

por Zhang, Shuai, Lu, Yuan, Jiang, Hong-Yu, Cheng, Zhi-Mei, Wei, Zi-Jing, Wei, Yun-Hao, Liu, Ting, Xia, Bai-Juan, Zhao, Xu-Ya, Huang, Yu, Zou, Xun, Liu, Rong, Zhou, Shi
Publicado 2021

Malic enzyme 2 promotes the progression of hepatocellular carcinoma via increasing triglyceride production

por Zhang, Shuai, Cheng, Zhi‐Mei, Yu, Jia‐LI, Lu, Kai, Xu, Sheng‐Jie, Lu, Yuan, Liu, Ting, Xia, Bai‐Juan, Huang, Zhi, Zhao, Xu‐Ya, He, Wei, Li, Jun‐Xiang, Cao, Wei, Huang, Yu, Wang, Ling, Zeng, Zhu, Zou, Xun, Liu, Rong, Zhang, Yu‐Sui, Wu, Xiao‐Ping, Jiang, Tian‐Peng, Zhou, Shi
Publicado 2021

Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)

por Zhu, Hai-Dong, Li, Hai-Liang, Huang, Ming-Sheng, Yang, Wei-Zhu, Yin, Guo-Wen, Zhong, Bin-Yan, Sun, Jun-Hui, Jin, Zhi-Cheng, Chen, Jian-Jian, Ge, Nai-Jian, Ding, Wen-Bin, Li, Wen-Hui, Huang, Jin-Hua, Mu, Wei, Gu, Shan-Zhi, Li, Jia-Ping, Zhao, Hui, Wen, Shu-Wei, Lei, Yan-Ming, Song, Yu-Sheng, Yuan, Chun-Wang, Wang, Wei-Dong, Huang, Ming, Zhao, Wei, Wu, Jian-Bing, Wang, Song, Zhu, Xu, Han, Jian-Jun, Ren, Wei-Xin, Lu, Zai-Ming, Xing, Wen-Ge, Fan, Yong, Lin, Hai-Lan, Zhang, Zi-Shu, Xu, Guo-Hui, Hu, Wen-Hao, Tu, Qiang, Su, Hong-Ying, Zheng, Chuan-Sheng, Chen, Yong, Zhao, Xu-Ya, Fang, Zhu-Ting, Wang, Qi, Zhao, Jin-Wei, Xu, Ai-Bing, Xu, Jian, Wu, Qing-Hua, Niu, Huan-Zhang, Wang, Jian, Dai, Feng, Feng, Dui-Ping, Li, Qing-Dong, Shi, Rong-Shu, Li, Jia-Rui, Yang, Guang, Shi, Hai-Bin, Ji, Jian-Song, Liu, Yu-E, Cai, Zheng, Yang, Po, Zhao, Yang, Zhu, Xiao-Li, Lu, Li-Gong, Teng, Gao-Jun
Publicado 2023